Bellerophon Therapeutics, Inc. Gains 168.37%

Tue 18 Feb 20 at 05:30 PM
Bellerophon Therapeutics, Inc. Gains 168.37%

Bellerophon Therapeutics, Inc. (BLPH:NASDAQ) shot up at $9.21, a gain of 168.4%. The stock appeared on our News Catalysts scanner on Tue 18 Feb 20 at 09:12 AM in the 'BIOTECH' category. From Mon 27 Jan 20, the stock recorded 14.29% Up Days and 26.67% Green Days

About Bellerophon Therapeutics, Inc. (BLPH:NASDAQ)

Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.

Share